EXABS-116-MPN Extended Abstract: Novel Therapies for PV

Lucia Masarova

doi:10.1016/S2152-2650(22)00647-4

EXABS-116-MPN Extended Abstract: Novel Therapies for PV

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S18-S20
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00647-4
State	Published - Oct 2022
Externally published	Yes

Keywords

hepcidin
Polycythemia vera
ropeginterferon
ruxolitinib
targeted agents

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/S2152-2650(22)00647-4

Cite this

@article{ba15acf4e67048a79e502e2d5edb4ebd,

title = "EXABS-116-MPN Extended Abstract: Novel Therapies for PV",

keywords = "hepcidin, Polycythemia vera, ropeginterferon, ruxolitinib, targeted agents",

author = "Lucia Masarova",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00647-4",

language = "English (US)",

volume = "22",

pages = "S18--S20",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

}

TY - JOUR

T1 - EXABS-116-MPN Extended Abstract

T2 - Novel Therapies for PV

AU - Masarova, Lucia

PY - 2022/10

Y1 - 2022/10

KW - hepcidin

KW - Polycythemia vera

KW - ropeginterferon

KW - ruxolitinib

KW - targeted agents

UR - http://www.scopus.com/inward/record.url?scp=85138168298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138168298&partnerID=8YFLogxK

U2 - 10.1016/S2152-2650(22)00647-4

DO - 10.1016/S2152-2650(22)00647-4

M3 - Article

C2 - 36163714

AN - SCOPUS:85138168298

SN - 2152-2650

VL - 22

SP - S18-S20

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

EXABS-116-MPN Extended Abstract: Novel Therapies for PV

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this